Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/oxford-university-press/choice-of-an-elisa-assay-for-screening-postmortem-blood-for-SJZd0JfC5S
References (11)
-
B. Perrigo, B. Joynt (1995)
Use of elisa for the detection of common drugs of abuse in forensic whole blood samplesJournal of the Canadian Society of Forensic Science, 28
-
S. Kerrigan, William Phillips (2001)
Comparison of ELISAs for opiates, methamphetamine, cocaine metabolite, benzodiazepines, phencyclidine, and cannabinoids in whole blood and urine.Clinical chemistry, 47 3
-
E. Foerster, Don Hatchett, J. Garriott (1978)
A Rapid, Comprehensive Screening Procedure for Basic Drugs in Blood or Tissues by Gas ChromatographyJournal of Analytical Toxicology, 2
-
(1993)
Clin. Chem -
R. Palmirotta, F. Verginelli, A. Cama, R. Mariani-Costantini, R. Frati (1998)
Setting cutoff concentrations for immunoassay screening of postmortem blood -
(1989)
J. Anal. Toxicol -
(1995)
Joynt -
M. Zweig, G. Campbell (1993)
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.Clinical chemistry, 39 4
-
S. Rasmussen, R. Cole, V. Spiehler (1989)
Methamphetamine in antemortem blood and urine by radioimmunoassay and GC/MS.Journal of analytical toxicology, 13 5
-
V. Spiehler, I. Collison, P. Sedgwick, S. Perez, S. Le, D. Farnin (1998)
Validation of an automated microplate enzyme immunoassay for screening of postmortem blood for drugs of abuse.Journal of analytical toxicology, 22 7
-
S. Ferrara, L. Tedeschi, G. Frison, G. Brusini, F. Castagna, B. Bernardelli, D. Soregaroli (1994)
Drugs-of-abuse testing in urine: statistical approach and experimental comparison of immunochemical and chromatographic techniques.Journal of analytical toxicology, 18 5
- Publisher
- Oxford University Press
- Copyright
- © Published by Oxford University Press.
- Subject
- Articles
- ISSN
- 0146-4760
- eISSN
- 1945-2403
- DOI
- 10.1093/jat/26.7.513
- Publisher site
- See Article on Publisher Site
Abstract
The object of this study was to evaluate the suitability of the Neogen Corp. microtiter plate enzyme-linked immunoassays (ELISA) for the screening of postmortem blood for amphetamine and methamphetamine and to choose the more appropriate assay for screening. Forty-seven postmortem whole blood specimens were obtained from drug-involved deaths, which had been screened and confirmed positive for methamphetamine and/or amphetamine. Eighty-five negative specimens were obtained from non-amphetamines-involved deaths, 17 of which involved decomposition. Specimens were tested using the Neogen Amphetamine Ultra and Neogen Methamphetamine/MDMA microtiter plate ELISA assays. No matrix effects were found for whole blood in these assays, and a dilution of 1:5 was chosen to facilitate pipetting and to bring the IC50 of the microtiter plate ELISA assay within the range of amphetamines concentrations encountered in medical examiner specimens. True positives, true negatives, false positives, and false negatives were determined relative to gas chromatography-mass spectrometry (GC-MS) and graphed for the ELISA. From these graphs and the receiver operating curves (ROC), the optimal cut-off for the Neogen Methamphetamine/MDMA ELISA was 50 ng/mL methamphetamine equivalents and the optimum cut-off for the Neogen Amphetamine Ultra ELISA was 100 ng/mL amphetamine equivalents. The Neogen Methamphetamine ELISA had a sensitivity of 93.6% ± 3.5% and a specificity of 77.6% ± 4.5% versus GC-MS at the cut-off of 50-ng/mL methamphetamine equivalents. The Neogen Amphetamine Ultra ELISA had a sensitivity of 95.7% ± 3.0% and a specificity of 72.9% ± 5.2% versus GC-MS at the 100-ng/mL amphetamine equivalents cut-off. The areas under the ROCs were equivalent for the two ELISA assays.
Journal
Journal of Analytical Toxicology – Oxford University Press
Published: Oct 1, 2002